GERON CORPGERON CORPGERON CORP

GERON CORP

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
−0.09CHF
Revenue estimate
‪31.21 K‬CHF
Market capitalization
‪2.04 B‬CHF
−0.273CHF
‪−155.02 M‬CHF
‪199.54 K‬CHF
‪479.35 M‬
Beta (1Y)
0.56

About Geron Corporation

CEO
John A. Scarlett
Website
Headquarters
Foster City
Employees (FY)
141
Founded
1990
FIGI
BBG00LVDHVL0
Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Foster City, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of GON is 2.856 CHF — it has increased by 0.21% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange GERON CORP stocks are traded under the ticker GON.
GERON CORP is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
GON stock is 0.21% volatile and has beta coefficient of 0.56. Check out the list of the most volatile stocks — is GERON CORP there?
GON earnings for the last quarter are −0.07 CHF per share, whereas the estimation was −0.09 CHF resulting in a 17.24% surprise. The estimated earnings for the next quarter are −0.09 CHF per share. See more details about GERON CORP earnings.
GERON CORP revenue for the last quarter amounts to ‪150.14 K‬ CHF despite the estimated figure of ‪54.01 K‬ CHF. In the next quarter revenue is expected to reach ‪68.62 K‬ CHF.
Yes, you can track GERON CORP financials in yearly and quarterly reports right on TradingView.
GON net income for the last quarter is ‪−43.76 M‬ CHF, while the quarter before that showed ‪−41.02 M‬ CHF of net income which accounts for −6.68% change. Track more GERON CORP financial stats to get the full picture.
Today GERON CORP has the market capitalization of ‪2.04 B‬, it has increased by 70.81% over the last week.
No, GON doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, GON shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GERON CORP stock right from TradingView charts — choose your broker and connect to your account.
GON reached its all-time high on Jan 23, 2023 with the price of 2.931 CHF, and its all-time low was 1.990 CHF and was reached on Aug 29, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 27, 2024, the company has 141.00 employees. See our rating of the largest employees — is GERON CORP on this list?
We've gathered analysts' opinions on GERON CORP future price: according to them, GON price has a max estimate of 5.31 CHF and a min estimate of 3.98 CHF. Read a more detailed GERON CORP forecast: see what analysts think of GERON CORP and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GERON CORP EBITDA is ‪−162.42 M‬ CHF, and current EBITDA margin is ‪−81.40 K‬%. See more stats in GERON CORP financial statements.